Title
Treatment of Systemic Sclerosis
Authoring Organization
Publication Month/Year
October 11, 2024
Last Updated Month/Year
October 15, 2024
Supplemental Implementation Tools
Document Type
Guideline
Country of Publication
European
Document Objectives
To update the European Alliance of Associations for Rheumatology (EULAR) recommendations for treatment of systemic sclerosis (SSc), incorporating new evidence and therapies. These updated recommendations include the first set of synthetic and biological targeted therapies recommended for key fibrotic manifestations of SSc as well as first-line combination treatment for newly diagnosed pulmonary artery hypertension and prioritise a new research agenda for the coming years.
Inclusion Criteria
Male, Female, Adult, Older adult
Health Care Settings
Ambulatory
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Treatment, Management
Diseases/Conditions (MeSH)
D012598 - Sclerosis
Keywords
systemic sclerosis, systemic sclerosis (SSc)
Source Citation
Del Galdo F, Lescoat A, Conaghan PG, Bertoldo E, Čolić J, Santiago T, Suliman YA, Matucci-Cerinic M, Gabrielli A, Distler O, Hoffmann-Vold AM, Castellví I, Balbir-Gurman A, Vonk M, Ananyeva L, Rednic S, Tarasova A, Ostojic P, Boyadzhieva V, El Aoufy K, Farrington S, Galetti I, Denton CP, Kowal-Bielecka O, Mueller-Ladner U, Allanore Y. EULAR recommendations for the treatment of systemic sclerosis: 2023 update. Ann Rheum Dis. 2024 Oct 11:ard-2024-226430. doi: 10.1136/ard-2024-226430. Epub ahead of print. PMID: 39393843.
Supplemental Methodology Resources
Data Supplement, Methodology Supplement, Methodology Supplement